Heparanase is an endo-β-D-glucuronidase which specifically cleaves extracellular and cell surface heparan sulphates (HS) at intrachain sites. Its enzymatic activity is strongly implicated in cell dissemination associated with tumor metastasis and inflammation. Indeed, heparanase gene is expressed in various tumors and its over-expression is correlated with increased tumor vascularity and metastatic potential of tumor cells. However, heparanase expression in non-invasive and non-immune tissue, including brain, has received less attention. Using RT-qPCR, western blot and histological analysis, we demonstrate in the adult rat that heparanase transcript is differentially expressed according to brain area, and that heparanase protein is mainly detected in neurons. Furthermore, we provide evidence that heparanase transcript and protein reach their greatest levels at early postnatal stages, in particular within the neocortex characterized by intensive structural plasticity. Using the in vitro model of PC12-induced neuronal differentiation, we suggest that developmental regulation of heparanase may coincide with axonal and dendritic pathfinding. At adulthood, we demonstrate that the increased heparanase transcript level correlates in the hippocampus with enhanced angiogenesis following repeated hypoxia exposures. Taken together, our results emphasize the potential importance of heparanase in brain homeostasis, both during development and adaptative responses to severe environmental challenges.
Introduction
Heparan sulfate (HS) chains present on HS proteoglycans (HSPGs) are abundantly found in the extracellular matrix (ECM) of the brain (Lander 1993 , Margolis & Margolis 1993 ). Due to their binding capacities (Deepa et al. 2004 , Lortat-Jacob et al. 2002 , Rapraeger 1995 , Taipale & Keski-Oja 1997 , HS chains sequester numerous bioactive molecules, such as growth factors (Esko & Selleck 2002 , Gallagher 2001 , Lyon & Gallagher 1998 , Taipale & Keski-Oja 1997 , Turnbull et al. 2001 . Heparanase is a mammalian endo-β-D-glucuronidase involved in degrading HS chains (Marchetti & Nicolson 2001 , Okada et al. 2002 , Pikas et al. 1998 , Thunberg et al. 1982 , and can thus liberate and increase the availability of growth factors (Ishai-Michaeli et al. 1990 , Parish 2006 known to play important roles in brain plasticity.
Heparanase gene sequence has been determined in various mammalian species, including human (Hulett et al. 1999 , Kussie et al. 1999 , Toyoshima & Nakajima 1999 , Vlodavsky et al. 1999 , rat (Hulett et al. 1999 ) and mouse (Miao et al. 2002) . Heparanase (EC:3.2.1-) is synthesized and secreted as a latent 65 kDa precursor and, as such, is retained at pericellular sites by binding to cell surface HS components (Gingis-Velitski et al. 2004 , Goldshmidt et al. 2001 . The full-length 65 kDa heparanase pro-enzyme undergoes proteolytic processing yielding an active heterodimer enzyme composed of 50 and 8 kDa polypeptides (Fairbanks et al. 1999 , Levy-Adam et al. 2003 , McKenzie et al. 2003 , Nardella et al. 2004 . In brain tissue, heparanase expression has mainly been studied in the context of tumor progression, and was attributed to invasive cells (Hulett et al. 1999 , Marchetti et al. 2000 , Nakajima et al. 1988 , Parish et al. 1987 , Parish et al. 2001 , Vlodavsky et al. 1999 . Recently, heparanase transcript has been shown to be constitutively expressed in the brain of hypoxia-tolerant blind mole rat (Nasser et al. 2005) , in neurons and white matter glia of rat spinal cord (Zhang et al. 2006) , and in cultured astrocytes (Marchetti et al. 2000) . Because (i) degradation of HS chains by heparanase appears to affect the integrity and functional state of tissues (Nasser et al. 2005) , (ii) HSPGs play a critical role in developmental processes (Perrimon & Bernfield 2000) , and (iii) transcripts of enzymes that catalyze polymerization of HS chains are up-regulated during postnatal development (Inatani & Yamaguchi 2003) , we hypothesized that brain expression of heparanase is profoundly altered throughout lifespan.
Furthermore, we explored whether brain expression of heparanase could be upregulated in adult rats under physiological situations associated with structural remodeling, such as hypoxia acclimatization (Miyamoto et al. 2005 , Patt et al. 1997 and enriched housing (Nithianantharajah & Hannan 2006 , Stranahan et al. 2006 , van Praag et al. 2000 . In these different physiological conditions, we thus analysed for the first time heparanase gene expression in distinct brain areas at both transcript level (using RT-quantitative PCR) and protein level (using histological and immunoblotting approaches).
Materials and methods

Design of animal studies
Animals. All animal procedures were in compliance with the guidelines of the European Union (directive 86/609), taken in the French law (decree 87/848) regulating animal experimentation. All efforts were made to minimize animal suffering and to reduce the number of animals used. SpragueDawley male rats (Harlan, France) were used throughout the experiments. They were housed in approved facilities, at 21 ± 1°C under diurnal lighting conditions (lights on from 06:00 to 18:00). Rats used during the first 3 weeks (w) of life arrived at 1 day old with foster dams. Rats used at 3 and 12 month (mo) old arrived at the animal facility 3 weeks before the experiments started. Pups were maintained in groups of 10 with their foster dam until postnatal day (d) 21. Older rats (3 mo and 12 mo) were maintained in groups of 5 in plastic cages. All rats (foster dams and adult rats) had free access to food and water.
Experiment 1: Determination of basal expression of heparanase in different brain structures.
Transcript levels of heparanase were determined in the hippocampus, the neocortex, the olfactory bulb, the dorsal part of thalamus and the hypothalamus of rats sacrificed at 3 mo (n=5). Localization of heparanase protein was performed on paraformaldehyde-fixed tissue in rats (n=5) of the same age.
Experiment 2: Determination of heparanase expression throughout postnatal development and ageing. Analysis of heparanase gene expression was performed in rats sacrificed at 2 d (n=8), 5 d (n=6), 1 w (n=8), 2 w (n=5), 3 w (n=5), 3 mo (n=5) and 12 mo (n=5). Transcript levels of heparanase were determined in the hippocampus, the neocortex, and the olfactory bulb at all ages mentioned.
Western blot analysis of immunoreactive heparanase was performed in the neocortex of the rats sacrificed at 2 d, 2 w, 3 mo and 12 mo. Localization of heparanase protein was performed on paraformaldehyde-fixed tissue in rats sacrificed at 5 d (n=5), 3 mo (n=5) and 12 mo (n=5).
Experiment 3: Effect of hypoxia preconditioning on heparanase mRNA expression. Hypoxia preconditioning consisted in 1 (H1) or 3 (H3) hypoxic exposures in 3 month-old rats. Hypoxia was realized by introducing rats within a chamber (Biospherix), the oxygen (O 2 ) proportion of which decreased progressively from 21% to 8% in one hour. Each hypoxia exposure was maintained at 8% O 2 during 6 hours. O 2 proportion was automatically regulated by the Pro-Ox system (Biospherix). In the H3 protocol, the 3 hypoxia exposures were carried out 4 days apart to facilitate the animal recovery. Transcript levels of heparanase were determined in the hippocampus of rats sacrificed immediately after the last hypoxic exposure, and then 1, 2 and 8 days later (Controls, n=4; H1 and H3, n=4 in each group at each time post-hypoxia considered). The surface area occupied by brain capillaries was measured in the hippocampus of rats sacrificed 3 days after the last hypoxic exposure (Controls, H1, and H3; n=3 in each group), by use of immunohistological detection on paraformaldehyde-fixed tissue of CD34, a vascular endothelial marker (Vaquero et al. 2000 , Young et al. 1995 .
Experiment 4: Effect of enriched housing on heparanase mRNA expression. Enriched environment "EE" consisted in housing 12 rats in a plexiglass box (80 cm x 80 cm x 40 cm) with plastic tubes, tunnels, ladders, 3 running wheels and toys that were rearranged 3 times a week during cage cleaning to encourage exploratory behavior and provide ongoing novelty to their environment. Standard environment "SE" consisted of housing 6 rats in polycarbonate boxes (40 cm x 20 cm x 18 cm).
Transcript levels of heparanase were determined in the hippocampus of rats (n=18), housed for 7 weeks [from weaning (21 days) to day 70], either in EE (n=9) or in SE (n=9). The effect of EE on hippocampal plasticity was verified by measuring neurogenesis at day 70, in rats housed in EE (n=3) or SE (n=3). Therefore, 60 day-old rats received 5 consecutive injections of 5'-bromo-deoxyuridine (BrdU; Sigma B5002), at 17:00 the first day, and at 12:00 and 17:00 the two following days. Rats were transcardially perfused 10 days after the first BrdU injection with 4% paraformaldehyde solution for counting of BrdU-incorporating cells within the dentate gyrus of the hippocampal formation, an active neurogenic zone in adults (Stranahan et al. 2006 , van Praag et al. 2000 .
In vitro experimental design
Cell culture. Rat PC12 cells were maintained in tissue culture flasks (175 cm²) in a humidified (90%) atmosphere of 95% air/ 5% CO 2 at 37°C. The medium ("PC12 complete medium", PC12CM) consisted of Dulbecco's modified Eagle's medium (DMEM, Eurobio # CM1DME60K), supplemented with 7% heat-inactivated horse serum, 7 % newborn bovine serum and antibiotics (80 units/mL penicillin and 80 mg/mL streptomycin). Culture medium was changed every other day. PC12 cells were harvested after mechanical dislodging, counted using a hemacytometer and then seeded in collagen I-treated 6-well plates (BD Biocoat) at the density of 300 cells / mm 2 in PC12CM.
Three days later, cells were treated at day 0 (D0) with 50 ng/mL mouse recombinant 2.5S NGF (Promega) in DMEM completed with 1% heat-inactivated normal horse serum and antibiotics. Cells were collected at D0, D1 and D3 and prepared for determination of heparanase transcript level (n=4 for each day). Western blot analysis of immunoreactive heparanase was performed at D0 and D3.
Immunocytochemical detection of heparanase protein was also performed in duplicate wells for each day.
Ex vivo procedures
Tissue preparation for transcript and protein level analysis. To determine the levels of heparanase mRNA and protein, rats were sacrificed following a lethal injection of pentobarbital (250 mg/kg).
Cerebral structures were rapidly removed and frozen in liquid nitrogen, and stored at -80°C.
Tissue preparation for histological analysis. To localize and characterize cells expressing heparanase in the brain, rats were deeply anesthetized (lethal intraperitoneal injection of pentobarbital at 250 mg/kg) and transcardially perfused with chilled 4% paraformaldehyde in 0.1M phosphate buffer at flow rates of 15 mL/min for 4 min (5 d) and 30 mL/min for 9 min (3 mo and 12 mo). After cryoprotection in 25% sucrose, brains were frozen in isopentane and stored at -80°C.
Methods
RT-real time PCR.
Variations in transcript levels were determined by real time PCR amplification of cDNAs of interest after RT of total mRNAs, as previously detailed (Nadam et al. 2007) . 
Production of a rabbit polyclonal anti-rat heparanase antibody.
A polyclonal immuno-affinity purified antibody directed against rat heparanase protein (GenBank NP_072127) has been produced (Covalab, Lyon, France) after immunization of a rabbit with two 13/14-residue peptides located within HS binding domains of the rat heparanase protein (Hulett et al. 1999) . The sequences of these peptides Colorimetric immunocytochemical detection of heparanase. After fixation in a 4% paraformaldehyde solution at 4°C, cells were intensively rinsed in PBS, incubated overnight at 4°C in PBS containing 0.5% Triton 100X, and then with the rabbit polyclonal anti-heparanase antibody (see above) diluted at 1/500 for ~ 24h at room temperature. After washes, cells were exposed overnight at 4°C to a biotinylated goat anti-rabbit IgG (AP187B, Chemicon) diluted at 1/2000. After washes, cells were incubated with avidin biotin peroxydase complex (1/500; Vectastain Elite ABC kit, Vector) and reacted with a DAB solution (Vector). Images were captured with a video camera 3CCD (DXC-9300;
Sony) coupled to an image analysis system (Visilog 6.3; Noesis).
CD-34 staining and measurement of the surface area occupied by blood vessels. Free-floating sections (40 µm thick) from paraformaldehyde-fixed tissue were incubated for ~ 24h at room temperature with a goat polyclonal antibody raised against CD-34 (Santa Cruz, sc-7045), diluted at 1/500. After washes, sections were exposed overnight at 4°C to a biotinylated donkey anti-goat IgG (705.066.147, Jackson ImmunoResearch) diluted at 1/5000. After washes, sections were incubated with avidin biotin peroxydase complex (1/1000, Vectastain Elite ABC kit, Vector) and reacted with a 3', 3-diaminobenzidine solution (Vector). Images were captured with a video camera 3CCD (DXC-9300, Sony) coupled to an image analysis system (Visilog 6.3, Noesis). The surface area occupied by CD-34+ blood vessels was measured within a 302 340 µm² window using the visilog software. at 1/1000. Sections were then coverglassed with Prolong Gold Antifade reagent (Molecular Probes), and analyzed as described above using a TCS SP2 confocal microscopy system (Leica).
Statistical Analysis
Data are expressed as mean ± SEM of the variables (mRNA level, BrdU+ cell number, blood vessel surface area) and are compared among groups by using one-way ANOVA followed by Fisher's protected Least Significance Differences (LSD) test.
Results
Constitutive expression of brain heparanase in young adult rats
In 3 month-old rats, transcript encoding heparanase was easily detected in all brain structures studied.
The hippocampus, the neocortex and the olfactory bulb exhibited similar tissue concentration of heparanase-mRNA, which was greater than that measured in the thalamus and the hypothalamus ( Figure 1A ). Immunolabeling of heparanase was neither associated with specific astroglial marker GFAP, nor with microglial specific marker OX-42 (data not shown).
Brain expression of heparanase during postnatal development and ageing
Heparanase transcript levels quantified in the hippocampus ( Figure 3A ), the neocortex ( Figure 3B ) and the olfactory bulb ( Figure 3C ) exhibited highly significant changes throughout postnatal development and ageing (p<0.001, ANOVA 1 in each brain area). The hippocampus and the neocortex displayed similar profiles as compared to the olfactory bulb. Indeed, (i) greatest heparanase transcript levels were observed at 2 and 5 days within the hippocampus and the neocortex, while the apparent peak was observed at 1 week in the olfactory bulb, and (ii) a significant increase in heparanase transcript level was noticed between 3 and 12 months in the hippocampus and the neocortex only.
Western blot analysis of immunoreactive heparanase revealed that zymogen and processed active forms of heparanase are specifically detected by the antibody used in the neocortex of 3 monthold rats ( Figure 4A ). Throughout postnatal development and ageing, the active form (50 kDa) was more abundant than the zymogen form (65 kDa). The level of the zymogen form was at its lowest value at postnatal day 2, gradually increased up to the adult stage (3 months) and remained stable during ageing. By contrast, the active form was the most abundant at postnatal day 2 and attained its stabilized level by the second postnatal week. The ratio "active form / zymogen form" thus reached its greatest value at postnatal day 2 ( Figure 4B ).
Immunohistochemical detection of heparanase performed at postnatal day 5 evidenced a dense punctuate signal in the stratum radiatum of area CA1 ( Figure 4C ). This punctuate signal may reflect the presence of the enzyme in numerous neuronal varicosities, as supported by the labeling observed within neuronal processes in the neocortex (see white arrow, Figure 4D ). The punctuate signal increased in density within the neuropile throughout development and ageing in the neocortex, as illustrated at 12 months ( Figure 4F ).
Heparanase could not be detected within granule cell bodies in the dentate gyrus (data not shown), pyramidal neurons of Ammon's horn ( Figure 4C ), and neocortical neurons ( Figure 4D ) at postnatal day 5. By contrast, later during ageing, heparanase was unequivocally detected in cell bodies of pyramidal neurons of Ammon's horn ( Figures 1C and 4E ) and neocortical neurons ( Figures 1C and   4F ) by 3 months, and in granule cell bodies of dentate gyrus by 12 months only (data not shown).
Increased heparanase expression during NGF-induced neuronal differentiation in PC12 cells
Heparanase transcript was constitutively expressed by exponentially growing PC12 cells, and transcript level was not affected by cell density (data not shown). During NGF-induced neuritic extension, we observed that heparanase transcript level gradually increased, reaching + 413% and + 1861% after 1 day and 3 days of NGF-treatment, respectively, as compared to controls (day 0) ( Figure   5A ). Increased heparanase mRNA levels were accompanied by the detection of the protein within neuritic extension (see black arrow, Figure 5B ). The zymogen form of heparanase (65 kDa) was detected at comparable levels in growing PC12 cells (D0) and 3 days (D3) after NGF-induced neuronal differentiation, while the active form of the enzyme was more abundantly found in NGFtreated cells ( Figure 5C ).
Hypoxia-induced angiogenesis correlates with enhanced heparanase transcript level in the hippocampus
A single transient severe hypoxic episode was not sufficient to elicit detectable angiogenesis, as measured by the surface area occupied by CD34-immunostained endothelial cells ( Figure 6A ), despite a significant increase in VEGF mRNA level (+ 218%, Figure 6B ). Heparanase gene expression remained unchanged immediately ( Figure 6B ), 1, 2 and 8 days (data not shown) after this single hypoxic exposure. By contrast, heparanase mRNA level was greatly enhanced following three severe hypoxic exposures, the apparent peak being observed immediately after the last hypoxic exposure (+ 262%, Figure 6B ), control levels being recovered 8 days later (data not shown). The apparent peak of VEGF transcript level (+ 353%, Figure 6B ) was measured immediately after the last hypoxic exposure, control levels being recovered 1 day later (data not shown). Following three severe hypoxic exposures, we measured a significant increase in the surface area occupied by CD34-immunostained endothelial cells (+ 36%, Figure 6A ).
Environmental enrichment fails to up-regulate heparanase transcript level
Environmental enrichment is a situation of increased brain plasticity (Nithianantharajah & Hannan 2006 ). Here we evidence in the hippocampus that rats housed in an enriched environment had an increased VEGF transcript level ( Figure 7B ), as previously reported (Cao et al. 2004) , and a greater number of BrdU-incorporating cells in the dentate gyrus ( Figure 7A ), indicating that neurogenesis was enhanced (Stranahan et al. 2006 , van Praag et al. 2000 . Despite the tissue remodeling accompanying increased neurogenesis, heparanase transcript level remained stable ( Figure 7B ).
Discussion
This study provides evidence that heparanase is mainly expressed by neurons in the brain throughout lifespan. We show that heparanase transcript level is increased in conditions associated with intensive structural plasticity, such as occurs during early postnatal maturation or during acclimatization to repeated hypoxic challenges.
In agreement with a prior study performed in the brain of adult blind mole rats (Nasser et al. 2005 ), we detected heparanase transcript and protein in the forebrain of mature Sprague-Dawley rats.
Tissue distribution analysis of heparanase transcript in blind mole rats revealed less abundant levels in the brain than in the kidney and the liver (Nasser et al. 2005 ). This analysis was performed using whole brain extracts and could not reveal whether brain expression of heparanase is greater in areas known to be the place of intensive structural plasticity at the adult age. The neocortex displays extraordinary dendritic plasticity in response to environmental changes (Hickmott & Ethell 2006) , and both the hippocampus and the olfactory bulb undergo intensive morphological changes associated with neurogenesis (Ming & Song 2005 ). Here we report for the first time that these three brain areas expressed the highest levels of heparanase transcript compared to the other brain areas examined, which may correlate with their capacity to undergo physiological structural remodeling.
While heparanase transcript has been detected both in neurons and astrocytes in the spinal cord of adult rats (Zhang et al. 2006) , our study provides evidence that heparanase protein is expressed above detectable levels within the rat forebrain by neurons exclusively. Heparanase is synthesized as a latent 65 kDa precursor and undergoes intracellular lysosomal processing yielding an active heterodimer enzyme composed of 50 and 8 kDa polypeptides (Fairbanks et al. 1999 , Levy-Adam et al. 2003 , McKenzie et al. 2003 , Nardella et al. 2004 ). In our study, the western blot analysis of immunoreactive heparanase indicates that the predominant form detected is the active 50 kDa form.
This result indicates that the major form of the heparanase detected in neurons is the active form of the enzyme, suggesting that lysosomal maturation of the latent 65 kDa pro-enzyme can occur in neurons.
We were not able to detect heparanase protein in vivo within astrocytes, contrasting with results obtained in vitro by others (Marchetti et al. 2000) and by us (unpublished data), using primary cultures of astrocytes. Heparanase expression that we demonstrate here to be restricted to neurons under basal conditions may extend to astrocytes under pathophysiological conditions, as suggested in vitro during invasion of melanoma cells within the brain parenchyma (Marchetti et al. 2000) . Recent studies revealed that heparanase protein can be found both in the cytoplasm and the nucleus of differentiating cells (Kobayashi et al. 2006 , Nobuhisa et al. 2007 . We detected heparanase protein only in the cytoplasm of neurons, which is in agreement with studies which reported high levels of heparanase protein in the cytoplasm of peripheral neurons in human normal tissues (Dong et al. 2000) . It is noteworthy that we detected heparanase protein in dendrites of pyramidal neurons in area CA1, which exhibit cell-surface HSPGs (Yamaguchi 2001) essential for the morphological maturation of spines (Ethell et al. 2001) , suggesting that co-localization of heparanase and HSPGs in neuronal processes may contribute to precisely control HSPG turn-over.
Prior studies have suggested that heparanase plays a critical role in the developing nervous system (Goldshmidt et al. 2001 ) and during neural cellular differentiation (Moretti et al. 2006 ), a hypothesis strengthened by our observation that (i) heparanase protein is present in numerous varicosities within the forebrain during the early postnatal period, and (ii) heparanase gene expression is increased during neuronal differentiation of PC12 cells. Both zymogen and active forms of heparanase have been shown to play biological functions (Goldshmidt et al. 2003 , Sotnikov et al. 2004 . Our observation that the 50 kDa form level is considerably high at early stages of postnatal development, as well as during NGF-induced neuritogenesis of PC12 cells, suggests that the major form of heparanase which is involved during development of the nervous system is the processed active heterodimer. Processes of neuronal death, neuronal differentiation (with dendritic growth and synaptogenesis) and axonal pathfinding that occur throughout the developmental period (Bayer et al. 1993 , Luhmann et al. 2003 ) are known to be regulated by HSPGs (Perrimon & Bernfield 2000 , Yamaguchi 2001 ). These cellular events require morphogen molecules including members of the Hedgehog, Wingless and fibroblast growth factor families (Bovolenta & Marti 2005 , Reuss & von Bohlen und Halbach 2003 , the signaling pathways of which are modified after binding to extracellular HS chains (Lin 2004 , Lin et al. 1999 , Ornitz & Leder 1992 , Rapraeger et al. 1991 , Yayon et al. 1991 . The presence of HS chains largely depends on both HS biosynthetic and degrading enzymes. HS synthesis is governed by (i) Ext genes, a family of glycosyltransferases that catalyse polymerization of alternating N-acetylglucosamine and glucuronic acid disaccharides that form the core of HS chains (Duncan et al. 2001) , and (ii) epimerases and sulfotransferases, that support sequential modifications of HS (Perrimon & Bernfield 2000) . The highest levels of transcripts encoding EXT-1, EXT-2 and some members of sulfotransferases have been measured in the forebrain of mice during the first postnatal week (Inatani & Yamaguchi 2003 , Yabe et al. 2005 . Here, by demonstrating that apparent peaks of transcript and active form of heparanase occur during the first postnatal week also in the forebrain, we can hypothesize that degradation of HS chains is increased.
Altogether, these results suggest that the turn-over of HS chains is enhanced during the early postnatal period, which may be critical in the modulation of morphogen signaling involved in the structural plasticity of the developing brain.
The observation that brain heparanase transcript level correlated with tissue plasticity throughout postnatal development encouraged us to investigate whether heparanase gene expression could be reactivated in adult rats under physiological conditions associated with intensive structural changes. We thus investigated whether physiological responses to severe environmental challenges, such as hypoxia, could imply an up-regulation of brain heparanase gene expression. Indeed, data obtained in hypoxia-tolerant blind mole rats suggest that high level of heparanase molecules may serve some species to adapt to severe hypoxic environments by facilitating tissue vascularization (Nasser et al. 2005) . Hypoxia-induced brain angiogenesis is considered to be regulated by similar mechanisms as pathological angiogenesis induced by tumors, involving increased expression of VEGF and heparanase (Bernaudin et al. 2002 , Chavez et al. 2000 , Greenberg & Jin 2005 , Plate 1999 , Plate et al. 1992 ). Here we show for the first time that the repetition of severe hypoxia episodes triggers a robust induction of both heparanase and VEGF mRNA in the adult rat hippocampus, associated with an increased vascularity. However, the upregulation of VEGF gene expression alone observed after a single episode of severe hypoxia is not a sufficient stimulus to promote enhanced vascularity. We thus suggest that the coordinate upregulation of heparanase and VEGF gene expression is the ideal condition to promote angiogenesis. In addition, the recent demonstration that upregulated heparanase level increases VEGF gene expression in tumor-derived cell lines (Zetser et al. 2006) Results are expressed in percent ± SEM of the value determined in 3 month-old rats. 
